134 related articles for article (PubMed ID: 14697643)
21. Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences.
Spreafico F; Ciceri S; Gamba B; Torri F; Terenziani M; Collini P; Macciardi F; Radice P; Perotti D
Oncotarget; 2016 Feb; 7(8):8908-15. PubMed ID: 26802027
[TBL] [Abstract][Full Text] [Related]
22. Routine karyotyping in Wilms tumor.
Betts DR; Koesters R; Plüss HJ; Niggli FK
Cancer Genet Cytogenet; 1997 Jul; 96(2):151-6. PubMed ID: 9216723
[TBL] [Abstract][Full Text] [Related]
23. Cytogenetically unrelated clones in different histologic components of a Wilms tumor.
Dolan M; Mascotti K
Cancer Genet Cytogenet; 2005 May; 159(1):63-8. PubMed ID: 15860360
[TBL] [Abstract][Full Text] [Related]
24. High frequency of loss of heterozygosity for 1p35-p36 (D1S247) in Wilms tumor.
Steinberg R; Freud E; Zer M; Ziperman I; Goshen Y; Ash S; Stein J; Zaizov R; Avigad S
Cancer Genet Cytogenet; 2000 Mar; 117(2):136-9. PubMed ID: 10704684
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
Grundy P; Telzerow P; Moksness J; Breslow NE
Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
[TBL] [Abstract][Full Text] [Related]
26. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
[TBL] [Abstract][Full Text] [Related]
27. Unbalanced translocation of chromosome 3p in Wilms' tumor.
Walton JM; Lee CL; Mikhail E; Welch JP; Gillis DA
J Pediatr Surg; 1992 Oct; 27(10):1311-4. PubMed ID: 1328583
[TBL] [Abstract][Full Text] [Related]
28. Two candidate tumor suppressor genes, MEOX2 and SOSTDC1, identified in a 7p21 homozygous deletion region in a Wilms tumor.
Ohshima J; Haruta M; Arai Y; Kasai F; Fujiwara Y; Ariga T; Okita H; Fukuzawa M; Hata J; Horie H; Kaneko Y
Genes Chromosomes Cancer; 2009 Dec; 48(12):1037-50. PubMed ID: 19760604
[TBL] [Abstract][Full Text] [Related]
29. Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse.
Natrajan R; Williams RD; Hing SN; Mackay A; Reis-Filho JS; Fenwick K; Iravani M; Valgeirsson H; Grigoriadis A; Langford CF; Dovey O; Gregory SG; Weber BL; Ashworth A; Grundy PE; Pritchard-Jones K; Jones C
J Pathol; 2006 Sep; 210(1):49-58. PubMed ID: 16823893
[TBL] [Abstract][Full Text] [Related]
30. Comparative genomic hybridization and its application to Wilms' tumorigenesis.
Getman ME; Houseal TW; Miller GA; Grundy PE; Cowell JK; Landes GM
Cytogenet Cell Genet; 1998; 82(3-4):284-90. PubMed ID: 9858837
[TBL] [Abstract][Full Text] [Related]
31. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
[TBL] [Abstract][Full Text] [Related]
32. Gain of 1q is a marker of poor prognosis in Wilms' tumors.
Segers H; van den Heuvel-Eibrink MM; Williams RD; van Tinteren H; Vujanic G; Pieters R; Pritchard-Jones K; Bown N;
Genes Chromosomes Cancer; 2013 Nov; 52(11):1065-74. PubMed ID: 24038759
[TBL] [Abstract][Full Text] [Related]
33. Comparative genomic hybridization analysis of Wilms tumors.
Steenman M; Redeker B; de Meulemeester M; Wiesmeijer K; Voûte PA; Westerveld A; Slater R; Mannens M
Cytogenet Cell Genet; 1997; 77(3-4):296-303. PubMed ID: 9284942
[TBL] [Abstract][Full Text] [Related]
34. Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour.
Natrajan R; Little SE; Sodha N; Reis-Filho JS; Mackay A; Fenwick K; Ashworth A; Perlman EJ; Dome JS; Grundy PE; Pritchard-Jones K; Jones C
J Pathol; 2007 Jan; 211(1):52-9. PubMed ID: 17103382
[TBL] [Abstract][Full Text] [Related]
35. Wilms tumors develop through two distinct karyotypic pathways.
Höglund M; Gisselsson D; Hansen GB; Mitelman F
Cancer Genet Cytogenet; 2004 Apr; 150(1):9-15. PubMed ID: 15041217
[TBL] [Abstract][Full Text] [Related]
36. Isochromosomes 7q and 17q in Wilms tumor.
Sreekantaiah C; Beneck D
Cancer Genet Cytogenet; 1998 Oct; 106(1):84-6. PubMed ID: 9772917
[TBL] [Abstract][Full Text] [Related]
37. Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters.
Klamt B; Schulze M; Thäte C; Mares J; Goetz P; Kodet R; Scheulen W; Weirich A; Graf N; Gessler M
Genes Chromosomes Cancer; 1998 Aug; 22(4):287-94. PubMed ID: 9669666
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Mertens F; Johansson B; Höglund M; Mitelman F
Cancer Res; 1997 Jul; 57(13):2765-80. PubMed ID: 9205089
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in Wilms tumor genetics.
Dome JS; Coppes MJ
Curr Opin Pediatr; 2002 Feb; 14(1):5-11. PubMed ID: 11880727
[TBL] [Abstract][Full Text] [Related]
40. Genetic changes of two Wilms tumors with anaplasia and a review of the literature suggesting a marker profile for therapy resistance.
Stock C; Ambros IM; Lion T; Zoubek A; Amann G; Gadner H; Ambros PF
Cancer Genet Cytogenet; 2002 Jun; 135(2):128-38. PubMed ID: 12127397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]